National Cancer Institute; Notice of Closed Meetings, 14384 [2019-07089]
Download as PDF
<![CDATA[
14384
Federal Register / Vol. 84, No. 69 / Wednesday, April 10, 2019 / Notices
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Network Clinical Trails.
Date: April 18, 2019.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Blvd., Suite 3208, Bethesda, MD 20892–9529,
(301) 435–6033, rajarams@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 4, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07085 Filed 4–9–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSK30RV082PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with grant
VerDate Sep<11>2014
20:36 Apr 09, 2019
Jkt 247001
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–3: NCI
Clinical and Translational R21 and Omnibus
R03.
Date: June 6–7, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Bethesda, MD
20892–9750, 240–276–7286, salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Integrating
Biospecimen Science Approaches into
Clinical Assay Development.
Date: June 18, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology &
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Bethesda, MD 20892–9750,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–
10:NCI Clinical and Translational R21 and
Omnibus R03.
Date: July 9, 2019.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology &
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Bethesda, MD 20892–9750,
240–276–5460, jfang@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 4, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07089 Filed 4–9–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2019–0131]
Port Access Route Study: The Areas
Offshore of Massachusetts and Rhode
Island
Coast Guard, DHS.
Notice of public meetings;
request for comments.
AGENCY:
ACTION:
The Coast Guard announces
an additional public meeting in
Montauk, NY, to receive comments on
a notice of study entitled ‘‘Port Access
Route Study: The Areas Offshore of
Massachusetts and Rhode Island’’ that
was published in the Federal Register
on Tuesday, March 26, 2019, (84 FR
11314). As stated in that document the
Coast Guard is conducting a
Massachusetts and Rhode Island Port
Access Route Study (MARIPARS) to
evaluate the need for establishing vessel
routing measures.
DATES: Three public meetings will now
be held to provide an opportunity for
oral comments about the MARIPARS on
Tuesday, April 23, 2019, from 6 p.m. to
9 p.m., Thursday, April 25, 2019, from
6 p.m. to 9 p.m., and on Monday, April
29, 2019, form 6 p.m. to 9 p.m. Written
comments and related material may also
be submitted to Coast Guard personnel
specified at the meetings. The comment
period for the notice of study closes on
May 28, 2019. All comments and related
material submitted after the meetings
must be received by the Coast Guard on
or before May 28, 2019. Commenters
should be aware that the electronic
Federal Docket Management System
will not accept comments after midnight
Eastern Daylight Time on the last day of
the comment period.
ADDRESSES: You may submit comments
identified by docket number USCG–
2019–0131 using the Federal
eRulemaking Portal at https://
www.regulations.gov. See the ‘‘Public
Participation and Request for
Comments’’ portion of the
SUPPLEMENTARY INFORMATION section for
further instructions on submitting
comments.
The public meeting on Tuesday, April
23, 2019, from 6 p.m. to 9 p.m., will be
held at Corless Auditorium (Watkins
Laboratory Building), University of
Rhode Island, Graduate School of
Oceanography at 215 South Ferry Road,
Narragansett, RI 02882–1197.
The public meeting on Thursday,
April 25, 2019, from 6 p.m. to 9 p.m.,
will be held at Flanagan Hall,
SUMMARY:
E:\FR\FM\10APN1.SGM
10APN1
]]>Agencies
[Federal Register Volume 84, Number 69 (Wednesday, April 10, 2019)]
[Notices]
[Page 14384]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07089]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-3: NCI Clinical and Translational R21 and Omnibus R03.
Date: June 6-7, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Bethesda, MD 20892-9750, 240-276-7286, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Integrating Biospecimen Science Approaches into Clinical
Assay Development.
Date: June 18, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology & Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-10:NCI Clinical and Translational R21 and Omnibus R03.
Date: July 9, 2019.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology & Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 4, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-07089 Filed 4-9-19; 8:45 am]
BILLING CODE 4140-01-P
